D-0610-2017 Class II Terminated

Recalled by AVKARE Inc. — Pulaski, TN

FDA drug recall D-0610-2017 was initiated by AVKARE Inc. on Feb 15, 2017 and is designated Class II. Reason for recall: Failed impurities/ degradation specifications: Product was above specification for unknown impurities. The recall status is terminated (terminated Jun 1, 2022). Affected quantity: 116 cartons.

Recall details

Product Type
Drugs
Report Date
Mar 29, 2017
Initiation Date
Feb 15, 2017
Termination Date
Jun 1, 2022
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
116 cartons

Product description

Famciclovir tablets, 500 mg, packaged in 30-count unit dose cartons, Rx only, Manufactured for: AvKARE, Inc., Pulaski, TN 38478, NDC 50268-307-13

Reason for recall

Failed impurities/ degradation specifications: Product was above specification for unknown impurities.

Distribution pattern

Nationwide

Code information

Lot #15152, Exp. 02/2018

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0610-2017
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0610-2017. Report a data issue: hello@regdatalab.com.